Most Important Data Point Going Foward in AGN/PFE Deal Will Be Path Forward Pfizer (PFE) Chooses - RBC
RBC Capital analyst Randall Stanicky offered some more commentary on Allergan (NYSE: AGN)/Pfizer (NYSE: PFE) after a call with noted ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)